Augustine Lawlor - Net Worth and Insider Trading

Augustine Lawlor Net Worth

The estimated net worth of Augustine Lawlor is at least $2 Million dollars as of 2024-04-25. Augustine Lawlor is the COO, 10% Owner of Leap Therapeutics Inc and owns about 707,710 shares of Leap Therapeutics Inc (LPTX) stock worth over $2 Million. Augustine Lawlor is the Director of Catalyst Biosciences Inc and owns about 15,608 shares of Catalyst Biosciences Inc (CBIO) stock worth over $119,706. Augustine Lawlor is also the Director of GlobeImmune Inc and owns about 463,267 shares of GlobeImmune Inc (GBIM) stock worth over $93. Details can be seen in Augustine Lawlor's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Augustine Lawlor has not made any transactions after 2020-02-25 and currently still holds the listed stock(s).

Transaction Summary of Augustine Lawlor

To

Augustine Lawlor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Augustine Lawlor owns 12 companies in total, including Catalyst Biosciences Inc (CBIO) , Leap Therapeutics Inc (LPTX) , and Cardiovascular Systems Inc (CSII) among others .

Click here to see the complete history of Augustine Lawlor’s form 4 insider trades.

Insider Ownership Summary of Augustine Lawlor

Ticker Comapny Transaction Date Type of Owner
CBIO Catalyst Biosciences Inc 2023-08-31 director
LPTX Leap Therapeutics Inc 2019-02-05 10 percent owner & Chief Operating Officer
CSII Cardiovascular Systems Inc 2009-03-02 director
GBIM GlobeImmune Inc 2016-03-18 director
PTI Proteostasis Therapeutics Inc 2016-02-17 10 percent owner
TRVN Trevena Inc 2014-01-30 10 percent owner
TLOG TetraLogic Pharmaceuticals Corp 2013-12-17 10 percent owner
RDUS Radius Health Inc 2011-05-17 10 percent owner
ALT Altimmune Inc 2009-07-28 10 percent owner
MTEM Molecular Templates Inc 2009-10-05 10 percent owner
YMTX Yumanity Therapeutics Inc 2016-02-10 10 percent owner
KA Kineta Inc 2016-02-10 10 percent owner

Augustine Lawlor Latest Holdings Summary

Augustine Lawlor currently owns a total of 3 stocks. Among these stocks, Augustine Lawlor owns 707,710 shares of Leap Therapeutics Inc (LPTX) as of February 5, 2019, with a value of $2 Million and a weighting of 95.01%. Augustine Lawlor owns 15,608 shares of Catalyst Biosciences Inc (CBIO) as of February 25, 2020, with a value of $119,706 and a weighting of 4.99%. Augustine Lawlor also owns 463,267 shares of GlobeImmune Inc (GBIM) as of March 18, 2016, with a value of $93 and a weighting of 0%.

Latest Holdings of Augustine Lawlor

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LPTX Leap Therapeutics Inc 2019-02-05 707,710 3.22 2,278,826
CBIO Catalyst Biosciences Inc 2020-02-25 15,608 7.67 119,706
GBIM GlobeImmune Inc 2016-03-18 463,267 0.00 93

Holding Weightings of Augustine Lawlor


Augustine Lawlor Form 4 Trading Tracker

According to the SEC Form 4 filings, Augustine Lawlor has made a total of 0 transactions in Leap Therapeutics Inc (LPTX) over the past 5 years. The most-recent trade in Leap Therapeutics Inc is the acquisition of 57,143 shares on February 5, 2019, which cost Augustine Lawlor around $999,999.

According to the SEC Form 4 filings, Augustine Lawlor has made a total of 1 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Catalyst Biosciences Inc is the sale of 69,401 shares on February 25, 2020, which brought Augustine Lawlor around $423,346.

According to the SEC Form 4 filings, Augustine Lawlor has made a total of 0 transactions in GlobeImmune Inc (GBIM) over the past 5 years. The most-recent trade in GlobeImmune Inc is the sale of 11,000 shares on March 18, 2016, which brought Augustine Lawlor around $17,050.

Insider Trading History of Augustine Lawlor

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Augustine Lawlor Trading Performance

GuruFocus tracks the stock performance after each of Augustine Lawlor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Augustine Lawlor is 13.8%. GuruFocus also compares Augustine Lawlor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Augustine Lawlor within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Augustine Lawlor's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Augustine Lawlor

Average Return

-3.33%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.14 13.8 34.4 -3.33 -16.27 -12.09
Relative Return to S&P 500(%) 4.77 7.68 29.51 -16.62 -30.62 -26.91

Augustine Lawlor Ownership Network

Ownership Network List of Augustine Lawlor

No Data

Ownership Network Relation of Augustine Lawlor


Augustine Lawlor Owned Company Details

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Augustine Lawlor is the director of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Biosciences Inc Insider Transactions

No Available Data

Augustine Lawlor Mailing Address

Above is the net worth, insider trading, and ownership report for Augustine Lawlor. You might contact Augustine Lawlor via mailing address: 55 Cambridge Parkway, Suite 301, Cambridge Ma 02142.

Discussions on Augustine Lawlor

No discussions yet.